Views

CrossRef citations to date

Altmetric

Letters to the Editor

Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection

Arthur Ponceleta Departement of Hematology, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, BelgiumCorrespondence[email protected]

Gil Verscheldenb Clinic of Infectious Disease, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium

Martin Colarda Departement of Hematology, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium

Marc Hildebrandc Department of Internal Medicine, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium

Maya Hitesb Clinic of Infectious Disease, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium

Nicolas Yind Department of Microbiology, Laboratoire hospitalier universitaire de Bruxelles (LHUB-ULB)- Université libre de Bruxelles, Brussels, Belgium

Charlotte Micheld Department of Microbiology, Laboratoire hospitalier universitaire de Bruxelles (LHUB-ULB)- Université libre de Bruxelles, Brussels, Belgium

David Grimaldie Departement of Intensive Care, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium

Virginie De Wildea Departement of Hematology, CUB-Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium

show all

Click to increase image sizeClick to decrease image size

Acknowledgement

REGN-COV2 (cocktail of two antibodies, casirivimab and imdevimab) was provided by Regeneron Pharmaceuticals, Inc. for the purpose of emergency compassionate use treatment

Ethical statement

First patient was not able to sign a written informed consent, his wife have accepted that his medical information’s was published. Two others patients signed a written informed consent.

The use of data was approved by Erasme University Hospital ethics committee

Author contributions

AP: Conceptualization, writing original draft, GV, NY, CM: Data curation, reviewing MH, DG, VDW, MC: reviewing, editing.

Disclosure statement

The authors declare no conflict of interest

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection

Information for

Open access

Opportunities

Help and information

Worsening of COVID-19 after chemotherapy in patients considered to have recovered from a SARS-CoV-2 infection

Acknowledgement

Ethical statement

Author contributions

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature